ViroGates A/S
NASDAQ CopenhagenTotal Valuation
ViroGates A/S carries a market capitalization of 78.90M, placing it among publicly traded companies globally. Its enterprise value stands at 70.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 78.90M |
| Enterprise Value | 70.22M |
Share Statistics
ViroGates A/S currently has 9.28M shares outstanding.
| Shares Outstanding | 9.28M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 9.80, and the price-to-book ratio stands at 5.26.
| PE Ratio | N/A |
| PS Ratio | 9.80 |
| PB Ratio | 5.26 |
| P/TBV Ratio | 5.26 |
| P/FCF Ratio | -12.83 |
| P/OCF Ratio | -12.83 |
Enterprise Valuation
| EV / Sales | 7.80 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
ViroGates A/S maintains a current ratio of 3.82, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.15, indicating elevated leverage, while an interest coverage ratio of -16.19 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.82 |
| Quick Ratio | 3.20 |
| Debt / Equity | 25.15 |
| Debt / EBITDA | -0.40 |
| Interest Coverage | -16.19 |
Financial Efficiency
| Return on Equity (ROE) | -82.44 |
| Return on Assets (ROA) | -47.79 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.03 |
Taxes
| Income Tax | -975,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
ViroGates A/S's stock has gained approximately 18.60465% over the past 52 weeks. The 50-day moving average sits at 10.54, while the 200-day moving average is 11.95.
| Beta (5Y) | N/A |
| 52-Week Price Change | 18.60465% |
| 50-Day Moving Average | 10.54 |
| 200-Day Moving Average | 11.95 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, ViroGates A/S generated 9.01M in revenue and converted that into -10.22M in net income, yielding earnings per share of -1.24. EBITDA reached -10.59M, while operating income came in at -10.59M.
| Revenue | 9.01M |
| Gross Profit | 7.07M |
| Operating Income | -10.59M |
| Pretax Income | -11.20M |
| Net Income | -10.22M |
| EBITDA | -10.59M |
| EBIT | -10.59M |
| Earnings Per Share (EPS) | -1.24 |
Balance Sheet
ViroGates A/S holds 22.28M in cash and equivalents against 4.22M in total debt, resulting in a net debt position of -18.06M. Total book value stands at 16.79M, with working capital of 19.62M providing operational flexibility.
| Cash & Cash Equivalents | 22.28M |
| Total Debt | 4.22M |
| Net Debt | -18.06M |
| Equity (Book Value) | 16.79M |
| Book Value Per Share | 2.04 |
| Working Capital | 19.62M |
Cash Flow
ViroGates A/S produced -6.88M in operating cash flow over the past twelve months.
| Operating Cash Flow | -6.88M |
| Capital Expenditures | N/A |
| Free Cash Flow | -6.88M |
| FCF Per Share | -0.83 |
Margins
ViroGates A/S operates with a gross margin of 78.46, reflecting its pricing power and cost economics. The operating margin of -117.60 and net profit margin of -113.54 provide insight into operational efficiency.
| Gross Margin | 78.46 |
| Operating Margin | -117.60 |
| Pretax Margin | -124.36 |
| Profit Margin | -113.54 |
| EBITDA Margin | -117.60 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -20.31 |
| FCF Yield | -7.79 |
Stock Splits
ViroGates A/S's most recent stock split took place on November 28, 2023 with a 125:162 split ratio.
| Last Split Date | 11/28/2023 |
| Split Ratio | 125:162 |
Scores
ViroGates A/S posts an Altman Z-Score of 5.61, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.61 |